Serum OX40 ligand as a biochemical regulator of Th2-dominant immune activation in asthma: An integrated cytokine network analysis

Ziyi Zhu, Shumin Li · 2026

Read Serum OX40 ligand as a biochemical regulator of Th2-dominant immune activation in asthma: An integrated cytokine network analysis by Ziyi Zhu, Shumin Li (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13601831.txt.

Description

Ziyi Zhu and Shumin Li report in 2026 a blood study of an immune signal in asthma. Asthma involves tangled networks of immune messengers, and OX40 ligand helps switch on the Th2 arm, the arm most tied to allergic airway inflammation. Whether blood levels of this molecule track with the wider activation pattern was unclear. The pair measured it alongside many immune factors in 82 asthma patients and 40 healthy controls.

Multiplex testing captured Th2, Th17, inflammatory, and calming mediators, plus chemokines and total IgE, while breathing tests measured lung function. Correlation and regression analyses searched for factors tied independently to OX40 ligand levels. Framing the molecule as a biochemical regulator, the authors place it inside the network rather than treating it as a lone marker. Their analysis shows how a single co-stimulatory signal relates to the broader immune activation profile driving asthma symptoms.

Catalog record

CREATORZiyi Zhu, Shumin Li
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE41077
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13601831

Browse the full library · About the Tower of Babel